Help collect valuable data from psoriasis patients in a clinical setting.
The National Psoriasis Foundation and CorEvitas, LLC launched a national psoriasis patient registry in 2015. The registry collects and analyzes data from psoriasis patients in a clinical setting.
The primary objective is to use these data to study the safety of FDA-approved systemic therapies. The secondary objective is to study comparative effectiveness, including patient-reported outcomes.
The registry is seeking patients who are:
Diagnosed with psoriasis
18 or older
Recently started a biologic within the past 12 months (combination therapy – for example, a biologic with a topical steroid – will not disqualify someone)
Patients complete questionnaires during routine appointments with their dermatologist. Their dermatologist follows up approximately every six months. The questionnaires take about 10 to 15 minutes.
How to Contribute to the Registry:
Ask your dermatologist if he or she is currently participating in the CorEvitas Registry.
The registry is still accepting a limited number of sites for dermatologists that treat patients with moderate to severe psoriasis with systemic treatments. Please contact CorEvitas if you are interested or have questions.
Questions or concerns?
Please reach out to us with any questions or if you are interested in participating in this program.